A FLOTILLA of five tankers carrying Iranian fuel for gaso­line-starved Venezuela is approaching the Caribbean, with the first vessel expected to reach the South American country’s waters today, according to Refinitiv Eikon tracking data.

Iran is supplying about 1.53 million barrels of gasoline and alkylate to Venezuela, according to both governments, sources and calculations made by TankerTrackers.com based on the vessels’ draft levels.

On Friday, in responding to questions in Parliament, National Security Minister Stuart Young said the Government has given an undertaking to do “absolutely nothing” to facilitate in any way the passage of any Iranian flagship carrying gasoline to Venezuela.

The shipments have caused a diplomatic standoff ­between Iran and Vene­zuela and the United States, as both nations are under US sanctions. Washington is considering measures in response, according to a senior US official, who did not elaborate on any options ­being weighed.

The United States recently beefed up its naval presence in the Caribbean for what it said was an expanded anti-drug operation. But a Pentagon spokesman, Jonathan Hoffman, said on Thursday he was not aware of any operations ­related to the Iranian cargoes.

“We have continued to say that Iran and Venezuela—both two outliers in the international order—(are) clearly violating international sanctions on both nations with this transaction,” he told reporters.

Venezuela’s defence minister said its military will escort the Iranian tankers once they reach the nation’s exclusive economic zone.

Iran-flagged tanker Fortune, the first in the flotilla, was approaching the Caribbean Sea on Friday. It has been navigating with its satellite signal on since it passed the Suez Canal earlier in May. The four other vessels are following the same route across the Atlantic Ocean, the Eikon data showed.

The OPEC-member country desperately needs fuel for up to 1,800 gasoline stations that have been partially closed for weeks due to insufficient supply from state-run ­PDVSA’s ­refineries, which until March worked at about ten per cent of their joint capacity of 1.3 million barrels per day.

PDVSA’s gasoline output is now limited to a single facility, the Amuay refinery, but most fuel produced is low octane as most of the country’s alkylation units are out of service, according to company sources. Imported alkylate could improve the quality of domestic gasoline.

Fuel sales at stations declined to about 40,000 bpd due to rationing, according to analysts.

Over a decade of mismanagement and lack of staff, combined with US sanctions that since 2019 have limited imports, Venezuela’s refineries are in poor condition. Shipments of equipment in flights by Iran’s Mahar Air have arrived in Venezuela in recent weeks to start repair work.

The US Treasury Department this week blacklisted the Chinese firm that provided the refinery parts. Beijing called the sanctions “illegal”.

RECOMMENDED FOR YOU

FINANCE Minister Colm Imbert will, in due course, be required to explain to the court why in his capacity as chairman of the Joint Select Committee (JSC) on Energy Affairs he, at one point, failed to convene a meeting of the JSC for more than 20 months and whether it was legal to do so.

WHILE Nestle saw an increase in demand for its products by households, there was a major decline in products that were sold to hotels and restaurants, which were ordered to be closed amidst the Covid-19 pandemic. Even though restaurants were allowed to reopen their doors on May 11, in-house dining still isn’t allowed and hotels are only allowed outdoor dining for their guests.

CANADA’S big five big commercial banks set aside close to C$11 billion in their last quarter in provisions for loans that are not being repaid according to schedule, which is called provisions for credit losses (PCL).

IMPORTANT changes are underway in the pharmaceutical industry. According to Becker’s Hospital Review, for many years pharmaceutical companies have moved away from researching drugs to treat infectious disease, being lured by the potential profits from drugs used to treat non-communicable diseases. Steph Sterling of the Roosevelt Institute points to this ‘failure’ of what she calls the fully market-based system in which new drugs and medical devices are developed.